A citation-based method for searching scientific literature

Enrico Domenici, David R Willé, Federica Tozzi, Inga Prokopenko, Sam Miller, Astrid McKeown, Claire Brittain, Dan Rujescu, Ina Giegling, Christoph W Turck, Florian Holsboer, Edward T Bullmore, Lefkos Middleton, Emilio Merlo-Pich, Robert C Alexander, Pierandrea Muglia. PLoS One 2010
Times Cited: 217







List of co-cited articles
1122 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of a biological signature for schizophrenia in serum.
E Schwarz, P C Guest, H Rahmoune, L W Harris, L Wang, F M Leweke, M Rothermundt, B Bogerts, D Koethe, L Kranaster,[...]. Mol Psychiatry 2012
147
19

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
Hidenaga Yamamori, Ryota Hashimoto, Tamaki Ishima, Fukuko Kishi, Yuka Yasuda, Kazutaka Ohi, Michiko Fujimoto, Satomi Umeda-Yano, Akira Ito, Kenji Hashimoto,[...]. Neurosci Lett 2013
58
32


Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.
Viktoria Stelzhammer, Frieder Haenisch, Man K Chan, Jason D Cooper, Johann Steiner, Hannah Steeb, Daniel Martins-de-Souza, Hassan Rahmoune, Paul C Guest, Sabine Bahn. Int J Neuropsychopharmacol 2014
61
21


A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia.
Tomihisa Niitsu, Tamaki Ishima, Taisuke Yoshida, Tasuku Hashimoto, Daisuke Matsuzawa, Yukihiko Shirayama, Michiko Nakazato, Eiji Shimizu, Kenji Hashimoto, Masaomi Iyo. Psychiatry Res 2014
43
30

Serum proteomic profiling of major depressive disorder.
M Bot, M K Chan, R Jansen, F Lamers, N Vogelzangs, J Steiner, F M Leweke, M Rothermundt, J Cooper, S Bahn,[...]. Transl Psychiatry 2015
59
20

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
11

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.
M K Chan, M-O Krebs, D Cox, P C Guest, R H Yolken, H Rahmoune, M Rothermundt, J Steiner, F M Leweke, N J M van Beveren,[...]. Transl Psychiatry 2015
85
12

Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.
Janusz K Rybakowski, Maria Skibinska, Pawel Kapelski, Leszek Kaczmarek, Joanna Hauser. Schizophr Res 2009
48
22

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.
Brian J Miller, Peter Buckley, Wesley Seabolt, Andrew Mellor, Brian Kirkpatrick. Biol Psychiatry 2011
912
10

Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation.
Emanuel Schwarz, Paul C Guest, Hassan Rahmoune, Daniel Martins-de-Souza, David W Niebuhr, Natalya S Weber, David N Cowan, Robert H Yolken, Michael Spain, Anthony Barnes,[...]. World J Biol Psychiatry 2012
38
26

Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia.
Emanuel Schwarz, Rauf Izmailov, Michael Spain, Anthony Barnes, James P Mapes, Paul C Guest, Hassan Rahmoune, Sandra Pietsch, F Markus Leweke, Matthias Rothermundt,[...]. Biomark Insights 2010
108
10

Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia.
Paul C Guest, Emanuel Schwarz, Divya Krishnamurthy, Laura W Harris, F Markus Leweke, Matthias Rothermundt, Nico J M van Beveren, Michael Spain, Anthony Barnes, Johann Steiner,[...]. Psychoneuroendocrinology 2011
86
11

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum.
Y Levin, L Wang, E Schwarz, D Koethe, F M Leweke, S Bahn. Mol Psychiatry 2010
78
12

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.
G I Papakostas, R C Shelton, G Kinrys, M E Henry, B R Bakow, S H Lipkin, B Pi, L Thurmond, J A Bilello. Mol Psychiatry 2013
102
10

Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study.
Sivasankar Devanarayanan, Hanumanthappa Nandeesha, Shivanand Kattimani, Siddharth Sarkar. Clin Chem Lab Med 2016
20
50

Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
Fahmy T Ali, Eman M Abd El-Azeem, Marwa A Hamed, Mohamed A M Ali, Nour M Abd Al-Kader, Ekrami A Hassan. Schizophr Res 2017
26
38

Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways.
Emanuel Schwarz, Nico J M van Beveren, Jordan Ramsey, F Markus Leweke, Matthias Rothermundt, Bernhard Bogerts, Johann Steiner, Paul C Guest, Sabine Bahn. Schizophr Bull 2014
58
15

Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.
Hong-Bo Xu, Ru-Fang Zhang, Dan Luo, Yuan Zhou, Ying Wang, Liang Fang, Wen-Juan Li, Jun Mu, Lihua Zhang, Yukui Zhang,[...]. Int J Neuropsychopharmacol 2012
65
13

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication.
Nishantha Kumarasinghe, Natalie J Beveridge, Erin Gardiner, Rodney J Scott, Surangi Yasawardene, Antoinette Perera, Jayan Mendis, Kanishka Suriyakumara, Ulrich Schall, Paul A Tooney. Int J Neuropsychopharmacol 2013
40
22

Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Janusz K Rybakowski, Agnieszka Remlinger-Molenda, Aleksandra Czech-Kucharska, Marlena Wojcicka, Michal Michalak, Jacek Losy. J Affect Disord 2013
33
27

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
9

Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project.
Diana O Perkins, Clark D Jeffries, Jean Addington, Carrie E Bearden, Kristin S Cadenhead, Tyrone D Cannon, Barbara A Cornblatt, Daniel H Mathalon, Thomas H McGlashan, Larry J Seidman,[...]. Schizophr Bull 2015
119
9


Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
8

Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls.
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, Matthias Rothermundt, F Markus Leweke, Paul C Guest, Sabine Bahn. J Proteomics 2012
46
17

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.
Vanja Nagy, Ozlem Bozdagi, Anna Matynia, Marcin Balcerzyk, Pawel Okulski, Joanna Dzwonek, Rui M Costa, Alcino J Silva, Leszek Kaczmarek, George W Huntley. J Neurosci 2006
322
8

Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.
Harpreet Sidhu, Lorraine E Dansie, Peter W Hickmott, Douglas W Ethell, Iryna M Ethell. J Neurosci 2014
91
8

TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex.
Pawel Okulski, Therese M Jay, Jacek Jaworski, Kamila Duniec, Joanna Dzwonek, Filip A Konopacki, Grzegorz M Wilczynski, Amelia Sánchez-Capelo, Jacques Mallet, Leszek Kaczmarek. Biol Psychiatry 2007
109
8

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
409
8

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
432
8

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
8

Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival.
Marlis Herberth, Dagmar Koethe, Yishai Levin, Emanuel Schwarz, Natalia D Krzyszton, Stephanie Schoeffmann, Hermelindis Ruh, Hassan Rahmoune, Laura Kranaster, Torsten Schoenborn,[...]. Proteomics 2011
61
13

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
8

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.
M A Frye, M Nassan, G D Jenkins, S Kung, M Veldic, B A Palmer, S E Feeder, S J Tye, D S Choi, J M Biernacka. Transl Psychiatry 2015
32
25

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
8

Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately.
Xiao-bin Wang, Ozlem Bozdagi, Jessica S Nikitczuk, Zu Wei Zhai, Qiang Zhou, George W Huntley. Proc Natl Acad Sci U S A 2008
221
7


Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia.
Sheng-Huang Chang, Szu-Yi Chiang, Chun-Ching Chiu, Chun-Chou Tsai, Huei-Huang Tsai, Chih-Yang Huang, Tsai-Ching Hsu, Bor-Show Tzang. Psychiatry Res 2011
42
16

Altered levels of acute phase proteins in the plasma of patients with schizophrenia.
Yifeng Yang, Chunling Wan, Huafang Li, Hui Zhu, Yujuan La, Zhengrui Xi, Yongshuo Chen, Lei Jiang, Guoyin Feng, Lin He. Anal Chem 2006
63
11

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients.
P C Guest, L Wang, L W Harris, K Burling, Y Levin, A Ernst, M T Wayland, Y Umrania, M Herberth, D Koethe,[...]. Mol Psychiatry 2010
97
7

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders.
Chiyo Shibasaki, Minoru Takebayashi, Kei Itagaki, Hiromi Abe, Naoto Kajitani, Mami Okada-Tsuchioka, Shigeto Yamawaki. Int J Neuropsychopharmacol 2016
16
43


MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.
Behnam Vafadari, Ahmad Salamian, Leszek Kaczmarek. J Neurochem 2016
127
7

Distinct molecular phenotypes in male and female schizophrenia patients.
Jordan M Ramsey, Emanuel Schwarz, Paul C Guest, Nico J M van Beveren, F Markus Leweke, Matthias Rothermundt, Bernhard Bogerts, Johann Steiner, Sabine Bahn. PLoS One 2013
32
18

High MMP-9 activity levels in fragile X syndrome are lowered by minocycline.
Magdalena Dziembowska, Dalyir I Pretto, Aleksandra Janusz, Leszek Kaczmarek, Mary Jacena Leigh, Nielsen Gabriel, Blythe Durbin-Johnson, Randi J Hagerman, Flora Tassone. Am J Med Genet A 2013
93
6

Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling.
Piotr Michaluk, Lenka Mikasova, Laurent Groc, Renato Frischknecht, Daniel Choquet, Leszek Kaczmarek. J Neurosci 2009
140
6

Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
Taisuke Yoshida, Masatomo Ishikawa, Tomihisa Niitsu, Michiko Nakazato, Hiroyuki Watanabe, Tetsuya Shiraishi, Akihiro Shiina, Tasuku Hashimoto, Nobuhisa Kanahara, Tadashi Hasegawa,[...]. PLoS One 2012
156
6

Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology.
Piotr Michaluk, Marcin Wawrzyniak, Przemyslaw Alot, Marcin Szczot, Paulina Wyrembek, Katarzyna Mercik, Nikolay Medvedev, Ewa Wilczek, Mathias De Roo, Werner Zuschratter,[...]. J Cell Sci 2011
138
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.